Domestic Identification, Genetic Diagnostic Kits Cost-Competitive

A domestic knowledge-based company has produced medical products that are considerably cheaper than their foreign counterparts.
Kawsar Biotech Company is geared to meet domestic needs in the fields of medicine, identification and genetic testing kits, according to the company’s CEO.
“The company has been able to produce a strategic medicine, i.e., the production of rabbit polyclonal antibody against human thymus,” Sirous Zeynali was also quoted as saying by the news portal of the Vice Presidency for Science and Technology.
“The medicine has been marketed since the fiscal 2021-22 with the permission of the Food and Drug Administration of the Islamic Republic of Iran and the approval of the Ministry of Health and Medical Education.”
The CEO noted that the company is one of five producers of molecular identification kits in the world.